California, USA (CU)_ Purissima, Inc., a top next-generation biotechnology health and wellness firm, announced the award of three new United States Patents, namely, 11,193,151, 11,242,546 and 11,242,547, further establishing the brand’s presence in the rapidly developing bioengineering field. The firm now owns five patents, boosting industry standards via unmatched technology that expands the market for consumer and medicinal applications.
George Rudenko, Co-Founder and CEO/CTO of Purissima, expressed pride over the accomplishment. He said, “We’re proud to receive these patent grants, officially recognizing the novelty and value of our proprietary technology platform”.
Rob Evans, Co-Founder, Chief Business and Strategy Officer, expressed hopes over the company’s performance. He said, “The work Purissima is doing is unparalleled and has vast potential to reshape fitness, beauty, and wellness industries as we know it. As our technology continues to advance, we remain committed to demonstrating a truly scalable and sustainable supply chain while preserving biodiversity in the process”.
The international wellness market is estimated to be worth over $1.5 trillion, growing at a rate of 5-10 percent per year, and Purissima continues to lead the industry in providing effective and affordable solutions to meet the most pervasive needs of life, including stress, pain, mood, and personal care. Purissima’s innovative platform can generate an almost infinite library of natural ingredients, including those with strong antibacterial, anti-inflammatory, and antiviral properties, by leveraging scientific advancements to gain access to rare and new substances without jeopardizing the environment.
This business continues to expand the impact of biosynthetic production by identifying the promising properties of these substances in the treatment of neurological and neurodegenerative disorders, acute pain, behavioral and cognitive disorders, inflammation, oxidation-related conditions, and metabolic disorders.
Purissima, Inc. is transforming how businesses get and use plant-based products by developing and manufacturing commercially effective microalgae biotechnology. Purissima’s objective is to give the world high-quality, pure, safe, and sustainable ingredients for products to enhance millions of people’s quality of life.
